已完成專案 | Accomplished Projects

基本資料

詳細內容

APSAVD 2019) is authorized by the Asia-Pacific Society of Arteriosclerotic Vascular Diseases (APSAVD). It has been held in Taiwan every two years since 1998 in Taiwan, and the conference has become increasingly international. Country-Australia.

The Institute of Blood Lipids and Arteriosclerosis of the Republic of China was established in 1995. Its purpose is to improve the basic and clinical research of dyslipidemia and arteriosclerosis, strengthen the prevention and treatment of arteriosclerosis, in order to improve the health of the people and promote international academic exchanges. Relevant academic seminars are held regularly at the annual conferences in March, June and September. Invited domestic and foreign experts in clinical basics and blood fat arteriosclerosis to participate in the discussions and exchange ideas with each other to gain new knowledge. In addition, they are also enthusiastically involved in blood fat arteries of Chinese people. Education on hardening prevention. In terms of international cooperation, in addition to continuing to actively participate in the conferences of the International Society of Arteriosclerosis, the Asia-Pacific Society of Arteriosclerosis and Vascular Diseases, and to improve the international visibility of Taiwan’s research on fatty arteriosclerosis in Taiwan, it has held a number of international conferences: the first Asia-Pacific Arteriosclerosis and Asia Vascular Diseases Conference, 2001 Taiwan Interventional Cardiology Symposium 2001, and the Fifth International Fatty Acid Conference in August 2002.

The Republic of China’s blood lipids and arteriosclerosis participated in the fight for the hosting rights of the 12th Asia-Pacific Conference on Arteriosclerosis and Vascular Diseases (APSAVD 2019) in 2016. More than 1,300 domestic and foreign experts and scholars are expected to visit the site